The alterations of CDKN2B, KMT5B, MAP2K1, PIK3CA, and chr9p were associated with hemorrhage (Table 2), and this may be due to the fact that most of them affect glioma cell proliferation and invasion. Here, CDKN2B is linked to central nervous system cancer.